Andelyn Biosciences to Implement Curator® Platform to Develop and Manufacture Gene Therapy AAV9-GM2 for Queen’s University to Treat GM2 Gangliosidoses
COLUMBUS, Ohio, Aug. 18, 2026 /PRNewswire/ — Andelyn Biosciences, Inc., a leading patient-focused cell and gene therapy Contract…